The tumor microenvironment orchestrates the sustained growth, metastasis and 
The morbidity and mortality rates of NSCLC are relatively high in China, with the 5-year survival rate less than 20%, 2 which is often due to the drug resistance developed after treatment for 1 year. 3, 4 Traditional anticancer strategies targeted cancer cells as a separate group, but tumor cells develop in a complex microenvironment, which is crucial for the development of drug resistance. 5 Hence, specifically targeting the tumor microenvironment and reversing drug resistance have been suggested in recent 10 years as new strategies for cancer therapy.
It is clear that the development of drug resistance does not depend solely on cancer cell autonomous defectsand is controlled by various important factors, including upregulation of ATP-binding cassette (ABC) transporter proteins, DNA damage repair, anti-apoptotic protein such as BCL-2 expression, and activation of prosurvival pathway induced by tumor microenvironments. 5 The tumor microenvironment has received recent attention as an important determinant of cancer cells drug resistance. 6 A dominant of tumor microenvironment is cancer-associated fibroblasts (CAF), 7 and many studies in recent 20 years have suggested that CAF play a prominent functional role for these cells in relation to cancer behavior. 8 Cancerassociated fibroblasts (CAF) are spindle-shaped mesenchymal cells with characteristics of smooth muscle cells and fibroblasts in tumor tissues. 9 They participate in tumor growth and metastasis in several ways, such as through secretion of various tumor growth factors drugs in various tumors, including breast cancer and colorectal carcinoma. 13 However, the specific mechanism of drug resistance induced by CAF remains unclear and it is still a challenge to effectively overcome the resistance and achieve better patient outcomes.
In the present study, enriched CAF were observed in tumor tissues from drug-resistant NSCLC patients. This tumor microenvironment with abundant CAF was demonstrated to facilitate the multi-drugsresistance in lung cancer. Furthermore, our studies revealed that NSCLC drug resistance was regulated in an insulinlike growth factor 2 (IGF2)/insulin-like growth factor receptor-1 (IGF-1R)/AKT/Sox2/P-GP pathway. The application of IGF-1R inhibitor could reverse the drug resistance and inhibit the growth induced by CAF. Based on our results, we found that CAF might cause NSCLC drug resistance development, and chemotherapy combined with IGF-1R inhibitor could be a potential strategy to treat NSCLC.
| MATERIALS AND METHODS

| Patient samples
Non-small cell lung cancer tumor samples were obtained sterilely 
| Primary culture of fibroblasts and tumor cells
We cultured fibroblast cells from NSCLC tumor tissues. Briefly, after washing the samples with RPMI-1640 medium and PBS, the tissues were cut into pieces as small as possible. Then tissues were removed to another dish with DMEM (HyClone, USA) containing ACCUMAX (SIGMA, USA) medium to digest at 37°C, 5% CO 2 incubator for 2 hours, followed by filtration (BD Biosciences, San Jose, CA, USA).
After washing with PBS, cell precipitation was collected and seeded into 6-well plates in 2-mL RPMI-1640 medium supplemented with 10% FBS overnight at 37°C. The next day, the medium was replaced with fresh medium to remove the nonadherent cells and the remaining cells were collected. After 5-10 passages, we sorted the CD90-positive cells with BD FACSAria III (USA) to collect fibroblasts and cultured the cells for further study. 14 We also obtained primary tumor cells from NSCLC tumor tissues. Briefly, primary tumor specimens were finely minced and then were treated with collagenase II/IV to digest for 2 hours at 
| Flow cytometry
It has been reported that CD90 was a marker for CAF. 15 Therefore, to detect the percent of CAF in lung cancer tumor samples, anti-CD90 human antibody (APC, eBioseicence, USA) was added to the cell suspension which was obtained from chemo-resistant and chemo-sensitive lung cancer patients' tissues. After incubating for 30 minutes at room temperature, samples were detected with a BD Accuri C6 (USA) the isotype was stained as a negative control.
For the doxorubicin uptake experiment, 5 9 10 4 A549 cells preco-cultured with CAF, IGF2, OSI-906, verapamil or not were seeded into a 6-well plate, followed by the doxorubicin treatment (1 lg/mL).
Then cells were harvested at different time points (1, 2, 4 and 8 hours) to detect the intracellular doxorubicin fluorescence intensity by flow cytometry (BD Accuri C6). 16 
| Viability tests
All the cell viability in this study was measured by MTT assay. 
| RNA interference
Human siRNA against Sox2 (siRNA1:5 0 -AAGGAGCACCC-3 0 and siRNA2:5 0 -GGATTATAAA-3 0 ) and control siRNA were purchased from Shanghai GenePharma. The transfection reagent and the siRNA complex were added to the A549 cells and incubated for 36 hours, followed by 24-hour IGF2 treatment. The cells were collected for further study. 
| Animal assay
| Statistical analysis
All data were presented as mean AE SEM. Graph Pad Prism 6.0 was used for data analysis (P < .05). Student t-test was used to analyze the difference between groups. Survival analysis was performed by
Kaplan-Meier method and evaluated using the log-rank test. P < .05 was considered significant. Figure 1C ). Furthermore, we tested the primary tumor cells which were isolated from clinical NSCLC lung cancer patients' tumor tissue (labeled as LCP1 in Figure S1B ) and found that pre-co-culturing with CAF from either chemo-sensitive (CS) or chemo-resistant (CR) samples could elevate the cell viability in LCP1 cells with cisplatin, etoposide and vinorelbine diatrate treatment ( Figure 1D ). These results suggest that CAF may participated in the acquisition of chemotherapeutic drugs resistance in NSCLC. Figure 2C ). Moreover, we used the recombinant IGF2 to pre- . The data are presented as the means AE SEM from 3 independent experiments. *P < .05; **P < .01; ***P < .001; ns, not statistically significant treat LCP1 and A549 cells, followed by cisplatin, etoposide and vinorelbine diatrate treatment. We found that IGF2 could elevate the cell viability ( Figures 2D and S2A) . It was further demonstrated in the fibroblast and tumor cell co-culturing system that the cell viability was decreased with the application of anti-IGF2
antibody ( Figures 2E and S2B) . Consistently, we found that the expression of IGF2 in chemo-resistant samples was significantly higher than in chemo-sensitive samples, as evidenced by immunohistochemistry staining ( Figure S2C) . It has been reported that Nanog, Oct4 and Sox2 are the main transcriptional factors in activating the AKT signaling pathway.
39-41
Thus, we analyzed the expression of Nanog, Oct4 and Sox2 in CAF-treated A549 and LCP1 cells, and we found that only the Sox2 was significantly upregulated in both A549 and LCP1 NSCLC cells after co-culturing with CAF ( Figure 3D,E) . Correspondingly, the inducible expression of Sox2 by CAF and/or recombinant IGF2 was verified using western blot ( Figure 3F ) and immunofluorescence ( Figure 3G ), The data indicated that CAF and/or IGF2 could induce the high expression of Sox2 and its nuclear translocation. In addition, adding anti-IGF2 reversed the inducible expression of Sox2 by CAF ( Figure 3H ). Furthermore, MK-2206 also markedly decreased the expression of Sox2, which was induced by IGF2 ( Figure 3I ). These data suggest that the inducible expres- | 949 3.5 | Cancer-associated fibroblasts regulate chemoresistance through P-GP to decrease drug retention and increase drug efflux
Because we have found that P-GP was upregulated in CAF and induced NSCLC chemo-resistance, we questioned the function of P-GP in this process. Strong evidence has been reported that P-GP may contribute to drug resistance in cancer by reducing drug uptake and enhancing drug efflux. 5, 42 To investigate whether accumulated CAF-induced chemo-resistance in NSCLC tissue was associated with the drug accumulation, doxorubicin was employed for its strong fluorescence in the assessment of intracellular drug content by immunofluorescence or flow cytometry. Our data showed that preco-culturing with CAF decreased the doxorubicin retention in the nucleus of A549 cells ( Figure 5A ) compared with monoculture. Correspondingly, we found that monoculture A549 cells absorbed doxorubicin in a time-dependent manner, while cells pre-co-cultured with CAF had less absorption over time ( Figure 5B ). In line with the data, we observed that the drug efflux in A549 cells pre-co-cultured with CAF was higher than control A549 cells at every time point ( Figure 5C ). These results indicated that CAF may decrease drug retention and increase drug efflux, leading to the anti-doxorubicin ability of A549 cells. Our previous data showed that adding recombinant IGF2 remarkably enhanced the chemo-resistance of A549 cells.
To further verify, we pre-treated A549 cells with recombinant IGF2, . The data was presented as the means AE SEM from 3 independent experiments. *P < .05; **P < .01; ***P < .001; ns, not statistically significant doxorubicin accumulation ( Figure 5D ). Similarly, we found that the doxorubicin absorption was damped but the efflux was increased in A549 cells in a time-dependent manner with IGF2 pretreatment, and the addition of IGF-1R inhibitor reversed the doxorubicin distribution ( Figure 5E,F) . Next, to further verify whether P-GP was involved in the drug efflux, we used verapamil, an inhibitor of P-GP, to treat A549 cells pre-co-cultured with CAF, and followed with doxorubicin treatment; we found that the doxorubicin retention in the nucleus was recorded again ( Figure 5G) . Furthermore, the cell death rate was significantly elevated in CAF co-cultured A549 cells when verapamil was added ( Figure 5H ). Taken together, we conclude that CAF induced chemo-resistance by P-GP to decrease drug retention and increase drug efflux. . The data are presented as the means AE SEM from 3 independent experiments. *P < .05; **P < .01; ***P < .001; ns, not statistically significant Along with the Sox2 nucleus translocation, the transcription of ABCB1 gene is enhanced and the expression of P-GP is evaluated to pump out the chemotherapy drug. Using OSI-906 to block IGF2/IGF-1R signal and combining with chemotherapy drug could reverse the drug resistance of lung cancer cells. The data was presented as the means AE SEM from 3 independent experiments. *P < .05; **P < .01; ***P < .001; ns, not statistically significant It was reported that CAF in lung cancer microenvironment are associated with cancer stemness maintenance, cell proliferation and cancer metastasis. 12, 58, 59 However, the specific relationship between CAF and cancer cell behavior remains unclear. In our study, we further examined the precipitating factors of chemotherapy failure in NSCLC patients, and found that a mass of CAF in tumor tissues would induce the development of cancer cell drug resistance via an IGF2/IGF-1R paracrine pathway. Hence, OSI-906, an inhibitor of IGF-1R, could serve as a potential agent to block the IGF2/IGF-1R paracrine pathway induced by CAF and be combined with multiple chemotherapeutic agents to effectively reverse the drug resistance and inhibit NSCLC progression.
In summary, our data described a novel role of CAF in resistance to multiple chemotherapeutic drugs in NSCLC. In addition, CAF regulate the drug resistance in a paracrine manner through the IGF2/ IGF-1R/Sox2/P-GP pathway. The combination of a selective smallmolecule inhibitor to IGF-1R with chemotherapeutic agents will be explored as a potential therapeutic strategy for anticancer therapy.
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